New cancer drug PLT012 enters human testing – could it shrink tumors?
Disease control
Recruiting now
This early-stage study tests a new drug, PLT012, in 36 adults with advanced solid tumors that have not responded to other treatments. The main goal is to find safe doses and check for side effects. Researchers will also measure drug levels in the blood and see if tumors shrink. A…
Phase: PHASE1 • Sponsor: Pilatus Biosciences Inc • Aim: Disease control
Last updated May 26, 2026 10:35 UTC